Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 5/20 | 0.41 |
| ▸ | STAT3 | P40763 | 3/20 | 0.37 |
| ▸ | CD209 | Q9NNX6 | 2/20 | 0.37 |
| ▸ | FGF2 | P09038 | 1/20 | 0.37 |
| ▸ | PTN | P21246 | 1/20 | 0.37 |
| ▸ | MDK | P21741 | 1/20 | 0.37 |
| ▸ | BDNF | P23560 | 1/20 | 0.37 |
| ▸ | FGF1 | P05230 | 1/20 | 0.36 |
| ▸ | PRKCA | P17252 | 1/20 | 0.36 |
| ▸ | AMY2A | P04746 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | SERPINC1 | P01008 | 2/20 | 0.35 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.35 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.35 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.35 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21233365 | 1.00 | F10 (0.41) | F10STAT3CD209FGF2PTN | |
| SCHEMBL22778350 | 1.00 | F10 (0.41) | F10STAT3CD209FGF2PTN | |
| SCHEMBL19773367 | 1.00 | F10 (0.41) | F10STAT3CD209FGF2PTN | |
| SCHEMBL19773431 | 1.00 | F10 (0.41) | F10STAT3CD209FGF2PTN | |
| SCHEMBL21233245 | 1.00 | F10 (0.41) | F10STAT3CD209FGF2PTN | |
| SCHEMBL24080164 | 1.00 | F10 (0.41) | F10STAT3CD209FGF2PTN | |
| SCHEMBL21233406 | 0.95 | F10 (0.43) | F10STAT3CD209FGF2PTN | |
| SCHEMBL19027025 | 0.90 | F10 (0.39) | F10STAT3CD209FGF2PTN | |
| SCHEMBL24083533 | 0.90 | F10 (0.39) | F10STAT3CD209FGF2PTN | |
| SCHEMBL19018816 | 0.90 | F10 (0.39) | F10STAT3CD209FGF2PTN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10864261-B2 | Synthetic vaccines against Streptococcus pneumoniae serotype 2 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2020-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10864261-B2 | Synthetic vaccines against Streptococcus pneumoniae serotype 2 | FUT5, SIGLEC7, ST6GAL1 | F10 621/4885STAT3 3696/4885CD209 341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.